Snapshots

Search

Search managers or tickers

GLUE Monte Rosa Therapeutics Inc

held 3 mo · 1 quarters on record GLUE across all managers
Position over time
PeriodShares% of portfolioActivityValue
Q2 2026 297,600 0.17% NEW $7M